Register entry
Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 32
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 2 |
| tablet, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| global blood therapeutics, inc, a subsidiary of pfizer inc. | 3 |
Exclusivity
Patents and exclusivities
32| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10017491 | OXBRYTAvoxelotor | product | Dec 2032 |
| 10034879 | OXBRYTAvoxelotor | substance, product | Dec 2032 |
| 10806733 | OXBRYTAvoxelotor | substance | Dec 2032 |
| 9018210 | OXBRYTAvoxelotor | substance, product | Nov 2033 |
| 9248199 | OXBRYTAvoxelotor | use | Jan 2034 |
| 10722502 | OXBRYTAvoxelotor | product | Feb 2035 |
| 11452720 | OXBRYTAvoxelotor | use | Feb 2035 |
| 9447071 | OXBRYTAvoxelotor | substance, product | Feb 2035 |
| 11020382 | OXBRYTAvoxelotor | use | Dec 2036 |
| 11944612 | OXBRYTAvoxelotor | use | Dec 2036 |
| 10493035 | OXBRYTAvoxelotor | product | Oct 2037 |
| Product | Exclusivity | Until |
|---|---|---|
| OXBRYTAVOXELOTOR | ODE-394 Orphan drug | Dec 2028 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| OXBRYTA | Voxelotor | tablet, film coated, oral | 72786-101NDA |
| OXBRYTA | Voxelotor | tablet, film coated, oral | 72786-102NDA |
| OXBRYTA | Voxelotor | tablet, for suspension, oral | 72786-111NDA |
Compare
Other companies listing voxelotor
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- Patheon Manufacturing Services LLC19 sites · 319 NDC
- Esteve Quimica, S.A.4 sites · 18 NDC
- MSN Life Sciences Private Limited2 sites · 167 NDC
- Cambrex Charles City, Inc.0 sites · 112 NDC
Enquiry
Common questions
- Is Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc. FDA approved?
- Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc. make?
- 3 products are listed under Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc. in the openFDA NDC Directory, most often as tablet, film coated; tablet, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.